Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common ; volume:11 ; number:1 ; day:14 ; month:12 ; year:2012 ; pages:1-10 ; date:12.2012
Malaria journal ; 11, Heft 1 (14.12.2012), 1-10, 12.2012
- Urheber
-
White, Nicholas J.
- Beteiligte Personen und Organisationen
-
Qiao, Li Guo
Qi, Gao
Luzzatto, Lucio
SpringerLink (Online service)
- DOI
-
10.1186/1475-2875-11-418
- URN
-
urn:nbn:de:1111-2016080633172
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- White, Nicholas J.
- Qiao, Li Guo
- Qi, Gao
- Luzzatto, Lucio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
The consequences of artemisinin resistance in falciparum malaria
Primaquine: the risks and the benefits
The duration of Plasmodium falciparum infections
Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
How antimalarial drug resistance affects post-treatment prophylaxis
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
The role of anti-malarial drugs in eliminating malaria
Malaria parasite clearance
Anaemia and malaria
Anti‐malarial drug effects on parasite dynamics in vivax malaria
Determinants of relapse periodicity in Plasmodium vivax malaria
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
The consequences of artemisinin resistance in falciparum malaria
Primaquine: the risks and the benefits
The duration of Plasmodium falciparum infections
Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
How antimalarial drug resistance affects post-treatment prophylaxis
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
The role of anti-malarial drugs in eliminating malaria
Malaria parasite clearance
Anaemia and malaria
Anti‐malarial drug effects on parasite dynamics in vivax malaria
Determinants of relapse periodicity in Plasmodium vivax malaria
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
The consequences of artemisinin resistance in falciparum malaria
Primaquine: the risks and the benefits
The duration of Plasmodium falciparum infections
Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
How antimalarial drug resistance affects post-treatment prophylaxis
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
The role of anti-malarial drugs in eliminating malaria
Malaria parasite clearance
Anaemia and malaria
Anti‐malarial drug effects on parasite dynamics in vivax malaria